investment


Blueberries Medical Announces Closing of C$ 2.1 Million Non-Brokered Private Placement and the Appointment of New Director

September 9th, 2021 - Ryan Allway

TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces the completion of a non-brokered private placement consisting of the sale of 20,813,817 common shares (“Common Shares”) at a price of C$0.10 per […]

SOL Global Jumps Into Michigan Cannabis Market with $20 Million Investment In Common C Holdings LP

August 24th, 2021 - Ryan Allway

TORONTO–(BUSINESS WIRE)–SOL Global Investments Corp. (“SOL Global” or the “Company“) (CSE: SOL) (OTCPK: SOLCF) (Frankfurt: 9SB) is pleased to announce that it has completed an investment in Common C Holdings LP (“Common C Holdings”), a Michigan-based, Delaware limited partnership that provides support services to state-compliant licensed cannabis operators. SOL Global invested USD$20 million in Common […]

Decibel Appoints Paul Wilson as CEO

June 22nd, 2021 - Ryan Allway

CALGARY, AB, June 22, 2021 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce  the appointment of Paul Wilson as its Chief Executive Officer, effective Wednesday, June 23rd. Emphasizing the Company’s objective for brand growth, Mr. Wilson brings CEO and President level experience from some of Canada’s top consumer brands […]

Newly Public Gage Cannabis on a Steep Growth Trajectory

May 11th, 2021 - Robin Lefferts

  Investors looking for value in the legal cannabis industry might be looking for some key indicators to point the way to companies of interest. Organizations operating in key and lucrative markets, showing fast revenue growth that looks like it will continue, and having experienced executives to guide the company through the various pitfalls of […]

Pre-Public Hempsana Moving Quickly in Cannabis Derivatives Market

May 7th, 2021 - Robin Lefferts

  Widely hailed as Cannabis 2.0, the current phase of growth in the legal cannabis market is fueled by cannabis-derived products based on oils, distillates, and isolates. These extracts contain various active ingredients, or cannabinoids, like CBD, THC, and rare cannabinoids such as CBN, CBG and Delta-8 THC. You may have noticed the explosion of […]

Psychedelics Wellness Company Delic: Proven Management Team with a Star-Studded Board

April 9th, 2021 - Ryan Allway

The psychedelics  sector is quickly evolving into a multi-billion-dollar industry with a growing number of publicly traded companies. As with any new industry, there are many companies backed by little more than financiers looking to make a quick dollar before moving on to the next opportunity, which makes it important for investors to know who’s […]

Major Growth in Canada’s Cannabis Vape and Concentrate Sales

March 29th, 2021 - Robin Lefferts

By now, most observers of the cannabis industry are familiar with the terms describing the various stages of industry development – Cannabis 1.0, Cannabis 2.0, Cannabis 3.7, etc. Whichever stage we are in according to the various definitions, most would agree there are very real growth opportunities as the industry matures. Deciphering which companies are […]

What Revive’s PharmaTher Acquisition Means for Investors

March 24th, 2021 - Ryan Allway

Revive Therapeutics Ltd. (CSE: RVV) (OTC: RVVTF) recently acquired the full rights to PharmaTher Inc.’s (CSE: PHRM) (OTC: PHRRF) intellectual property pertaining to psilocybin—the most popular psychedelic compound in clinical development worldwide. The assets include preclinical research from the National Health Research Institutes in traumatic brain injury and stroke, as well as three key provisional […]

Do International Cannabis Companies Deserve More Attention?

March 2nd, 2021 - Ryan Allway

Since the legal cannabis industry burst onto investors’ radar in 2014 the U.S. market and the Canadian markets have been the primary focus. The potential of the U.S. market in terms of sheer size, and the Canadian national recreational program and export opportunities have captured investor attention.  Interestingly, there are some U.S. and Canadian companies […]

There’s no Magic Answer to the Question, “Can I Patent Magic Mushrooms?”

February 24th, 2021 - Ryan Allway

“Patent pending” is a phrase you are likely familiar with. You have seen it stamped on the side of some doodad at the mall or heard it on the TV show that you are binge watching, and you think to yourself, “Wow, I wish I could invent something that everyone thinks is really cool”. Most […]

How California is Dominating the Cannabis Brand Landscape

February 24th, 2021 - Ryan Allway

California is well known for its brand dominance—from its Hollywood studios to its Napa Valley wines. As a tastemaker across industries, the state’s cannabis brands are well-positioned to follow in these footsteps and expand across the United States if and when the federal government legalizes cannabis nationwide. At the same time, manufactured products including gummies, […]

Cannabis 3.0: Investing in Profitability

February 23rd, 2021 - Ryan Allway

If you’ve been following the public cannabis markets for the past decade, you’ve seen a myriad of changes that can be bundled into a few major categories: The Canadian build up, the rise of the US MSO and the race to get profitable.  During the Canadian build up, call it Cannabis 1.0, it was all […]

Psychedelic Clinical Trials & Who’s Behind Them

February 18th, 2021 - Ryan Allway

The psychedelics industry has experienced unprecedented growth over the past few years, driven by a combination of emerging research, regulatory support and investor interest. With a growing number of organizations in the space, it can be difficult for investors to keep track of what clinical trials are ongoing and what opportunities lie in the horizon. […]

Kaya Reaches Beyond Oregon

February 17th, 2021 - Ryan Allway

  In early 2014, in a small office in Hollywood, Florida, the management of what is today Kaya Holdings made the strategic decision to transition their existing small-cap publicly traded biofuels company away from alternative energy and exclusively toward the cultivation and retail of legal cannabis. This was no ordinary decision; Colorado and Washington had […]

ManifestSeven Doubles Down on Emerald Triangle with New Facility

February 9th, 2021 - Ryan Allway

California’s legal cannabis industry is on track to reach $7.2 billion in sales by 2024, according to Arcview Market Research and BDS Analytics, which represents a 19% compound annual growth rate. The Emerald Triangle region is widely considered to be the epicenter of that growth with its ideal microclimate and world-class operators. Let’s take a […]

How to Invest in Cannabis Delivery

January 18th, 2021 - Ryan Allway

Delivery services of all kinds experienced record-breaking growth in 2020 thanks to a global pandemic that has depressed retailers, restaurants, and grocery stores. Of course, these trends are just an acceleration of an existing transition from brick-and-mortar to e-commerce—a trend that many in the cannabis industry are betting will be transformative. Let’s take a look […]

CBD Innovator, HempFusion, Makes Successful Debut on TSX

January 13th, 2021 - Ryan Allway

  HempFusion Wellness Inc. (TSX: CBD-U) shares soared over 65% following their successful debut on the Toronto Stock Exchange (TSX) on Wednesday, January 6, 2021. Cannabidiol, or CBD, has become one of the most popular health and wellness products in the world over the past couple of years. According to Research and Markets, the global […]

Pure Extracts Unveils Plans for Functional Mushrooms

November 30th, 2020 - Ryan Allway

  There are more than 2,000 species of edible fungi and at least 15 have functional benefits that support overall health. Like other superfoods, functional mushrooms have antioxidant properties that support the immune system, dietary fiber to aid in healthy digestion and numerous other benefits to everything from mental clarity to skin health. At the […]

CBD Makes Its Way into Mainstream Retail

November 19th, 2020 - Ryan Allway

The U.S. market for CBD products is projected to reach $23.7 billion by 2023, according to Brightfield Group, representing a seven-fold increase in the market’s size. While it’s one of the fastest-growing subsets of the multi-trillion-dollar wellness industry, CBD products remain absent from most mass-market retailers. CVS became the first large-scale retailer to offer CBD […]

CB Therapeutics: Producing Rare Cannabinoid & Psychedelic Molecules at Scale

November 10th, 2020 - Ryan Allway

The cannabis industry has evolved from the legalization of dried cannabis to an increasingly detailed understanding of individual cannabinoids. While THC and CBD are the two most common, researchers are increasingly interested in CBC, THCV and other rare cannabinoids that could have specific and desirable effects on certain medical indications. The problem is that these […]

3 Psychedelische Business Modelle (und was am besten für Investoren ist)

October 23rd, 2020 - Ryan Allway

Die Psychedelikaindustrie hat das Interesse von Pharmaunternehmen geweckt, die nach sichereren und effektiveren Produkten suchen, um ungedeckte medizinische Bedürfnisse im Bereich der psychischen Gesundheit zu befriedigen. Während psychedelische Moleküle vielversprechend sind, verlangen die Pharmahersteller, dass die Moleküle durch wissenschaftliche Techniken verbessert werden, um bestimmte therapeutische Ziele zu erreichen und Toxizitäten zu reduzieren. Es gibt drei […]

Christina Lake Cannabis: Disrupting the Market with Ultra-Low Cost Production

September 17th, 2020 - Ryan Allway

Cannabis is quickly moving from a hot commodity to a regular commodity as a growing number of licensed producers put pressure on prices. While the government hopes that falling prices push out black market competition, many companies have seen their margins contract after just a short time in production—spelling danger for investors in the space. […]

3 Beverage Mega-Trends that Investors Should Watch

June 15th, 2020 - Ryan Allway

Beverages play a key role in almost everyone’s life—from coffee in the morning to an alcoholic drink at dinner or with friends. While the same large companies have dominated the space for years, smaller innovators have experienced the fastest growth rates as they launch high-growth products before getting snapped up by larger competitors. The key […]

Israel Gives Final Go-Ahead for Cannabis Exports: Here’s Who Could Profit

June 5th, 2020 - Ryan Allway

Israel gave final approval in mid-May for exports of medical cannabis, paving the way for more than one billion shekels ($273 million) in annual revenue. The country will become one of just three countries that have approved the export of medical cannabis to countries that permit its use—after Canada and the Netherlands— when the law […]

How to Invest in a Global Cannabis Portfolio

May 20th, 2020 - Ryan Allway

North America’s cannabis industry may capture the most headlines, but there are many cannabis frontier markets to keep in mind. In fact, North America represented just 25%, or $86 billion, of the $344 billion global cannabis market in 2018, according to New Frontier Data. Asia, Europe, Africa, Latin America, Oceana and the Caribbean are all […]

THC BioMed Reports Growing Revenue & Profitability

April 22nd, 2020 - Ryan Allway

Cannabis investors had already been shifting from “unproven potential” to “profitability” over the past several quarters prior to the global health crisis. With the COVID-19 outbreak, investors have fled previous investments to profitable companies that aren’t reliant on costly or dilutive funding to sustain their operations. THC BioMed Intl Ltd. (CSE: THC) recently recorded its […]

Ehave, Inc. Appoints Dr. Mark Braunstein as Chief Psychedelic Officer

April 6th, 2020 - Ryan Allway

Dr. Braunstein is recognized worldwide in Psychedelic Psychiatry, which entails treating psychiatric disorders with psychedelics Dr. Braunstein is a renowned expert on psychedelic therapy and addiction. As a pioneer in psychedelic medicine research, he specializes in the treatment of ADHD, depression, anxiety, bipolar disorder, substance abuse, oppositional defiance, personality disorders, and treatment resistance. He has […]

Science-driven Brand Delivers 5 Perfected Cannabis Highs

April 6th, 2020 - Robin Lefferts

What happens when the investment environment surrounding cannabis companies evaporates amid concerns about overvaluations and lack of returns? And then, a worldwide pandemic reverses years of economic growth almost overnight, plunging economies into near-instant depression? One thing that happens is some quality companies become distressed, offering investors the opportunity to purchase a stake at a […]

Psychedelics: Investing in the Perfect BrainStorm

April 6th, 2020 - Ryan Allway

Psychedelics are rapidly becoming both a mainstream treatment option and investment opportunity. With growing interest among researchers, forward-thinking companies are starting to build a presence in the space.  In this article, we will take a look at the growing body of therapeutic evidence for psychedelics. How decriminalization is gaining ground, and how Ehave Inc. (OTC: […]

Cannabis Brands Want Their Own Store, CalEthos Deems it Essential

April 3rd, 2020 - Robin Lefferts

Cannabis Shelf Space Deemed Essential What is the ideal setting for a brand to showcase its wares to the retail consumer? It is certainly not a crowded store with hundreds of brands competing for limited shelf space and consumer attention. Every brand out there would much rather have its own store, featuring its own product […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading